Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Exchange Rate Effect (2023 - 2025)

Cytokinetics (CYTK) has disclosed Exchange Rate Effect for 3 consecutive years, with -$632000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect changed N/A to -$632000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.0 million, a N/A change, with the full-year FY2025 number at -$715000.0, down 442.11% from a year prior.
  • Exchange Rate Effect was -$632000.0 for Q4 2025 at Cytokinetics, down from -$270000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $27000.0 in Q1 2024 to a low of -$632000.0 in Q4 2025.
  • A 3-year average of -$167500.0 and a median of -$73000.0 in 2023 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 1100.0% in 2025; the steepest drop was 1100.0% in 2025.
  • Cytokinetics' Exchange Rate Effect stood at -$20000.0 in 2023, then tumbled by 530.0% to -$126000.0 in 2024, then plummeted by 401.59% to -$632000.0 in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Exchange Rate Effect are -$632000.0 (Q4 2025), -$270000.0 (Q1 2025), and -$126000.0 (Q3 2024).